SAN DIEGO — Imaging techniques are poised to streamline the diagnosis of giant cell arteritis in the United States, after gaining traction elsewhere, according to a speaker at the 2024 Congress ...

Among patients with GCA, those with low vs high CRP levels more often presented with anterior ischemic optic neuropathy and limb claudication.

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School ...

Takayasu Arteritis (TAK): A rare granulomatous vasculitis primarily affecting the aorta and its branches, most commonly diagnosed in younger women.

"FDA approves AbbVie’s upadacitinib for giant cell arteritis" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

Tapering tocilizumab leads to a longer relapse-free period in patients with giant cell arteritis, compared with abrupt discontinuation, according to data published in Seminars in Arthritis and ...

Patients with giant cell arteritis started tocilizumab therapy an average of 43 days after diagnosis, partly because of delays in insurance approval. Overall, 82 patients (average age, 73 years ...

on Thursday released topline results from the Phase 3 GCAptAIN study evaluating Cosentyx (secukinumab) for newly diagnosed or relapsing giant cell arteritis (GCA). Giant cell arteritis is an ...

Patients with giant cell arteritis treated daily with prednisone were randomized to one of three different groups: the control group that received placebo medications; a group that received 7.5 ...